Health Trials

About this trial

PACE-AF is a prospective, observational patient registry designed to evaluate the impact of pacemaker algorithms on atrial fibrillation (AF) incidence, progression, and clinical outcomes in patients implanted with dual-chamber pacemakers. The registry aims to include 400-500 patients with longitudinal follow-up. Primary outcomes are progression to permanent AF and all-cause mortality. Secondary outcomes include quality of life, hospitalization, and cardiovascular events.

Eligibility criteria

Qualifiers

• Age ≥ 18 years

Implantation of a dual-chamber permanent pacemaker

Ability to provide informed consent

Willingness to participate in long-term follow-up

Disqualifiers

• Single-chamber pacemaker or Cardiac Resynchronization Therapy device at baseline

Life expectancy < 1 year due to non-cardiac comorbidities

Inability to comply with follow-up visits or device interrogation

Participation in another clinical trial that could interfere with study endpoints

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Tver State Medical University Clinical Center170000, Tver'Tver Oblast, Russia

Sponsors and collaborators

Ilya Lukin

Lead sponsor

Source ClinicalTrials.gov